T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune (Q43486818)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 December 2008

Language	Label	Description	Also known as
English	T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune	scientific article published on 25 December 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

0 references

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

Andréa Teixeira de Carvalho

4

object named as

Andréa Teixeira-Carvalho

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Renato Sathler-Avelar

3

object named as

Renato Sathler-Avelar

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Márcio Sobreira Silva Araújo

1

object named as

Márcio Sobreira Silva Araújo

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Renata Aline de Andrade

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Mariléia Chaves Andrade

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Leonardo Rocha Vianna

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Wilson Mayrink

7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Alexandre Barbosa Reis

8

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Luiz Cosme Cotta Malaquias

9

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Maria Norma Mello

10

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Olindo Assis Martins-Filho

11

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

language of work or name

0 references

publication date

25 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1008-1017

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Leishmaniasis: current situation and new perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

The current status of zoonotic leishmaniases and approaches to disease control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Lutzomyia longipalpis and the eco-epidemiology of American visceral leishmaniasis, with particular reference to Brazil: a review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

The immunology of Leishmania infection and the implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Immunogenicity assay of the Leishmune vaccine against canine visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Immunology of canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Infection of a canine macrophage cell line with leishmania infantum: determination of nitric oxide production and anti-leishmanial activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Cytokine expression during the outcome of canine experimental infection by Leishmania infantum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Despite Leishvaccine and Leishmune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Vaccination of dogs against Leishmania (Viannia) braziliensis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Immune effector mechanism in parasitic infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Histopathology, parasite density and cell phenotypes of the popliteal lymph node in canine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Characterization of the cellular immune response in American cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

The immunodominant T helper 2 (Th2) response elicited in BALB/c mice by the Leishmania LiP2a and LiP2b acidic ribosomal proteins cannot be reverted by strong Th1 inducers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

The cell biology of T-dependent B cell activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Fc receptors and immunity to parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.104

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.11.104

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43486818&oldid=1989788489"